Unusual Localised Skin Reaction due to Ondansetron: Case Series


Affiliations

  • Sumandeep Vidyapeeth Deemed University, Department of Pharmacology, Smt B. K. Shah Medical Institute and Research Centre, Gujarat, 391760, India
  • GMERS Medical College, Department of Paediatric, Vadodara, Gujarat, 390021, India
  • Nootan Medical College and Research Centre, Department of Pharmacology, Visnagar, Gujarat, 384315, India
  • Sumandeep Vidyapeeth Deemed University, Department of Physiology, Smt B.K Shah Medical Institute and Research Centre, Vadodara, Gujarat, 391760, India

Abstract

Ondansetron is an antiemetic drug that belongs to 5-hydroxytryptamine (5-HT3) receptor antagonists group. It has been widely used to treat nausea and vomiting due to chemotherapy, post surgery or due to any other gastrointestinal problem with 5-HT3 receptors involvement. The typical adverse drug reactions of Ondansetron include headache, dizziness, constipation or diarrhoea. Here, we have observed the skin reaction around the site of injection following Ondansetron administration. Recognition of this hypersensitivity reaction may allow better preparedness of clinicians to manage this condition.


Keywords

Ondansetron, 5-HT3, Skin Reaction

Subject Discipline

Pharmacology

Full Text:

References

Varshney RK, Jain G. Localized urticaria with intravenous ondansetron: A case report with literature review. Acta Medica International 2014;1(1):39-40.

Alame MM, Chamsy DJ, Zaraket H. Pityriasis rosea-like eruption associated with ondansetron use in pregnancy. Br J Clin Pharmacol. 2018;84(5):1077-1080. doi:10.1111/bcp.13560

Mori-Vogt S, Blazer M. Palonosetron for the prevention of chemotherapyinduced nausea and vomiting. Expert Rev Anticancer Ther. 2013;13:919-36. doi: 10.1586/14737140.2013.814412. PubMed PMID: 23984894.

Singhal AK, Kannan S, Gota VS. 5HT3 antagonists for prophylaxis of postoperative nausea and vomiting in breast surgery: a meta-analysis. J Postgrad Med. 2012;58:23-31. PubMed PMID: 22387645.

Finn AL. Toxicity and side eff ects of ondansetron. Semin Oncol. 1992; 19(4): 53-60.

Russell D,Kenny GNC. 5HT3 antagonists in postoperative nausea and vomiting. Br J Anaesth 1992; 69:63-68.

Sharma A, Raina V. Generalised seizures following Ondansetron. Ann Oncol 2001; 12(1):131-2.

Tolan MM, Fuhrman TM, Tsueda K, Lippmann SB: Perioperative extrapyramidal reactions associated with Ondansetron. Anesthesiology 1999; 90:340-1.

Mehra KK, Gogtay NJ, Ainchwar R, Bichile LS. Hypersensitivity to intravenous ondansetron: a case report. J Med Case Rep. 2008;2:274. Published 2008 Aug 14. doi:10.1186/1752-1947-2-274

Sharma A, Raina V: Generalised seizures following Ondansetron. Ann Oncol 2001, 12(1):131-132.

Ondansetron: drug information - UpToDate [Internet]. Available at: https%3A%2F%2Fwww.uptodate.com%2Fcontents%2Fondansetron-drug information%3Fsource%3Dsearch_result%26amp%3Bsearch%3Dondansetron%26amp%3BselectedTitle% 3D1~132 (last accessed 3 July 2020).


Refbacks

  • There are currently no refbacks.